论文部分内容阅读
Acute ischemic stroke(AIS)is a common medical problem associated with significant morbidity and mortality worldwide.A small proportion of AIS patients meet eligibility criteria for intravenous thrombolysis(IVT)with recombinant tissue plasminogen activator